MiMedx names new accounting chief post fraud settlement

Accounting fraud

Biotech company MiMedx Group, which last November settled an alleged case of accounting fraud with the SEC, announced the appointment of William Phelan as senior vice president and chief accounting officer.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.